Blog
RSS FeedPosted by Michael Wonder on 24 Jul 2022
New campaign to promote COVID-19 oral antiviral treatments
22 July 2022 - The Australian Government today launched a new advertising campaign to encourage eligible Australians to access life-saving COVID-19 ...
Posted by Michael Wonder on 21 Jul 2022
‘Increasing problem’: Australia facing shortages of more than 320 medicines
21 July 2022 - More than 320 items are becoming hard to find as Australia faces increasing shortages in a crucial ...
Posted by Michael Wonder on 17 Jul 2022
Medicine affordability hardships bite for Australians as cost of living pressures build
18 July 2022 - Izzy Sheppard feels like they are constantly treading water to stay on top of medical expenses. ...
Posted by Michael Wonder on 17 Jul 2022
Prescription medication prices to rise
15 July 2022 - The price of nearly 900 prescription medications will rise by as much as $7 on October ...
Posted by Michael Wonder on 15 Jul 2022
PBAC Public Summary Documents (first time rejections and deferrals) – March 2022 meeting
15 July 2022 - The Public Summary Documents (first time rejections and deferrals) from the March 2022 PBAC meeting are now ...
Posted by Michael Wonder on 15 Jul 2022
Chief Medical Officer’s statement on standard of care on COVID-19 oral antiviral treatments in residential aged care facilities
15 July 2022 - A statement from Professor Paul Kelly, Australian Government Chief Medical Officer, about the standard of care on ...
Posted by Michael Wonder on 11 Jul 2022
Drug Utilisation SubCommittee outcome statement
8 July 2022 - The outcome statement from the June 2022 DUSC meeting is now available. ...
Posted by Michael Wonder on 10 Jul 2022
Millions of Australians to gain access to COVID treatments
10 July 2022 - Eligibility for potentially lifesaving COVID-19 antiviral treatments will be widened from tomorrow, Monday 11 July. ...
Posted by Michael Wonder on 10 Jul 2022
COVID-19 oral treatment eligibility expanded from 11 July 2022
10 July 2022 - From 11 July 2022, more Australians at higher risk of developing severe COVID-19 will be able to ...
Posted by Michael Wonder on 10 Jul 2022
PBAC recommendation for amendments to COVID-19 oral treatment restrictions
10 July 2022 - The PBAC recommended changes to the PBS eligibility criteria for both molnupiravir (Lagevrio) and nirmatrelvir and ritonavir ...
Posted by Michael Wonder on 08 Jul 2022
Doctors, pharmacists call for better support to prescribe anti-virals
8 July 2022 - Pandemic measures including home delivery of medicines and subsidised Telehealth appointments should be reinstated to allow ...
Posted by Michael Wonder on 07 Jul 2022
Expanded eligibility for fourth COVID-19 vaccine dose
7 July 2022 - An additional 7.4 million people will now be eligible to receive a fourth COVID-19 vaccine dose ...
Posted by Michael Wonder on 06 Jul 2022
Agenda for July 2022 PBAC meeting (version 3)
6 July 2022 - It is actually version 4. ...
Posted by Michael Wonder on 04 Jul 2022
2022 October price disclosure cycle – indicative prices
4 July 2022 - Indicative 1 October 2022 prices resulting from the 2022 October Cycle of Price Disclosure have now been ...
Posted by Michael Wonder on 04 Jul 2022
DoH publishes revised agenda for next week's PBAC meeting
4 July 2022 - Apparently the webpage was last updated on 29 July 2022. ...